ECSP078057A - Formulaciones de estrógenos conjugados y bazedoxifeno - Google Patents

Formulaciones de estrógenos conjugados y bazedoxifeno

Info

Publication number
ECSP078057A
ECSP078057A EC2007008057A ECSP078057A ECSP078057A EC SP078057 A ECSP078057 A EC SP078057A EC 2007008057 A EC2007008057 A EC 2007008057A EC SP078057 A ECSP078057 A EC SP078057A EC SP078057 A ECSP078057 A EC SP078057A
Authority
EC
Ecuador
Prior art keywords
conjugated estrogens
bazedoxifen
formulations
bazedoxifene
salt
Prior art date
Application number
EC2007008057A
Other languages
English (en)
Inventor
Ramarao S Chatlapalli
Arwinder Nagl
Pelt Lawrence Van
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP078057(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP078057A publication Critical patent/ECSP078057A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

La presente invención tiene relación con formulaciones de dosificación sólidas conteniendo estrógenos conjugados y bazedoxifeno, o una sal de ellos. En algunas modalidades las composiciones incluyen un núcleo comprende estrógenos conjugados y a lo menos una cobertura que comprende bazedoxifeno o una sal de ellos.
EC2007008057A 2005-06-29 2007-12-27 Formulaciones de estrógenos conjugados y bazedoxifeno ECSP078057A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
ECSP078057A true ECSP078057A (es) 2008-01-23

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007008057A ECSP078057A (es) 2005-06-29 2007-12-27 Formulaciones de estrógenos conjugados y bazedoxifeno

Country Status (19)

Country Link
US (1) US20070003623A1 (es)
EP (1) EP1898888A2 (es)
JP (1) JP2008545012A (es)
KR (1) KR20080031037A (es)
CN (1) CN101252921A (es)
AR (1) AR054806A1 (es)
AU (1) AU2006263638A1 (es)
BR (1) BRPI0612586A2 (es)
CA (1) CA2613102A1 (es)
CR (1) CR9597A (es)
EC (1) ECSP078057A (es)
IL (1) IL188223A0 (es)
NI (1) NI200700331A (es)
NO (1) NO20080002L (es)
PA (1) PA8684501A1 (es)
PE (1) PE20070188A1 (es)
RU (1) RU2395286C2 (es)
TW (1) TW200738283A (es)
WO (1) WO2007002823A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005232640B2 (en) * 2004-04-08 2011-07-28 Wyeth Bazedoxifene acetate solid dispersion formulations
AR064014A1 (es) * 2006-11-29 2009-03-04 Wyeth Corp Tabletas bi-capa de estrogeno/moduladores selectivos de receptores de estrogeno (serm) y estrogeno/progestina
CN101631536A (zh) * 2007-01-12 2010-01-20 惠氏公司 片中片组合物
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
CA2775599A1 (en) * 2009-10-27 2011-05-12 Wyeth Llc Bazedoxifene formulations with antioxidants
RU2012149115A (ru) * 2010-04-20 2014-05-27 Сипла Лимитед Фармацевтическая композиция
WO2012016056A1 (en) * 2010-07-29 2012-02-02 Entropic Communications, Inc. Method and apparatus for cross polarization and cross satellite interference cancellation
BR112013029199B1 (pt) * 2011-05-13 2022-02-08 Eb Ip Hybritabs B.V. Dispositivo de distribuição de dois fármacos
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬雌激素组合物
PL3310333T3 (pl) 2015-06-18 2020-07-13 Estetra Sprl Ulegająca rozpadowi w jamie ustnej jednostka dawkowana zawierająca składnik estetrolowy
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
NZ516453A (en) * 1999-07-06 2004-04-30 Endorech Inc Methods of treating and/or suppressing weight gain using a selective estrogen receptor modulator
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
KR20050010886A (ko) * 2002-06-13 2005-01-28 와이어쓰 바제독시펜 치료 방식
UA86055C2 (ru) * 2004-04-07 2009-03-25 Уайет Кристаллическая форма в базедоксифена ацетата
TWI346105B (en) * 2004-04-07 2011-08-01 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
AU2005232640B2 (en) * 2004-04-08 2011-07-28 Wyeth Bazedoxifene acetate solid dispersion formulations
RU2006132181A (ru) * 2004-04-08 2008-05-20 Вайет (Us) Базедоксифен аскорбат в качестве селективного модулятора рецептора эстрогена

Also Published As

Publication number Publication date
NI200700331A (es) 2009-02-16
CN101252921A (zh) 2008-08-27
BRPI0612586A2 (pt) 2010-11-23
CA2613102A1 (en) 2007-01-04
JP2008545012A (ja) 2008-12-11
NO20080002L (no) 2008-03-12
KR20080031037A (ko) 2008-04-07
RU2395286C2 (ru) 2010-07-27
EP1898888A2 (en) 2008-03-19
IL188223A0 (en) 2008-03-20
AR054806A1 (es) 2007-07-18
RU2007148071A (ru) 2009-08-10
PE20070188A1 (es) 2007-03-16
AU2006263638A1 (en) 2007-01-04
US20070003623A1 (en) 2007-01-04
WO2007002823A2 (en) 2007-01-04
CR9597A (es) 2008-03-06
WO2007002823A3 (en) 2007-08-09
TW200738283A (en) 2007-10-16
PA8684501A1 (es) 2007-01-17

Similar Documents

Publication Publication Date Title
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ITTO20000779A0 (it) Composizioni farmaceutiche.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
DE60325255D1 (de) Duftzusammensetzung
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
DK3219705T3 (da) Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
PT1354873E (pt) Sal de perindopril e as composicoes farmaceuticas que o contem
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
BRPI0614413A2 (pt) composto, e, composição farmacêutica
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
NO20031095D0 (no) Farmasöytiske sammensetninger
ATE410154T1 (de) Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol
BRPI0614412A2 (pt) composto, e, composição farmacêutica
IL190063A (en) The history of cycloalkanes is preserved, their medicinal preparations and their uses
CL2004001921A1 (es) Compuestos derivados de pirimidina; composicion que los cintoene utiles como insecticidas y antihelminticos.
ITMI20052077A1 (it) Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
EA200900266A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ